Gene amplification in PNETs/medulloblastomas: Mapping of a novel amplified gene within the MYCN amplicon

Journal of Medical Genetics

Volumn 37, Issue 7, 2000, Pages 501-509

  Frühwald, Michael C ^a   Brodeur, Garrett M ^d   Plass, Christoph ^a   O'Dorisio, M Sue ^a,e   Rush, Laura J ^a   Reiter, Jill L ^b   Smiraglia, Dominic J ^a   Wenger, Gail ^a   Costello, Joseph F ^c   White, Peter S ^d   Krahe, Ralf ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

Medulloblastoma; NAG amplification; PNET; RLGS

Indexed keywords

DNA FRAGMENT;

ARTICLE; CHILD; CHROMOSOME 2P; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; FEMALE; GENE AMPLIFICATION; GENE MAPPING; GENE SEQUENCE; HUMAN; HUMAN TISSUE; MALE; MEDULLOBLASTOMA; MOLECULAR CLONING; NEUROECTODERM TUMOR; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 1642618077     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.37.7.501     Document Type: Article

References (44)

1. Caputy AJ, McCullough DC, Manz HJ, Patterson K, Hammock MK. A review of the factors influencing the prognosis of medulloblastoma. The importance of cell differentiation. J Neurosurg 1987;66;80-7.
2. Harisiadis L, Chang CH. Medulloblastoma in children: a correlation between staging and results of treatment. Int J Radiat Oncol Biol Phys 1977;2:833-41.
3. Jenkin D, Goddard K, Armstrong D, et al. Posterior fossa medulloblastoma in childhood: treatment results and a proposal for a new staging system. Int J Radiat Oncol Biol Phys 1990;19:265-74.
4. Duffner PK, Cohen ME, Myers MH, Heise HW. Survival of children with brain tumors: SEER Program, 1973-1980. Neurology 1986;36:597-601.
5. Burnett ME, White EC, Sih S, von Haken MS, Cogen PH. Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system. Cancer Genet Cytogenet 1997;97:25-31.
6. Biegel JA, Janss AJ, Raffel C, et al. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system. Clin Cancer Res 1997;3:473-8.
7. Scheurlen WG, Schwabe GC, Joos S, Mollenhauer J, Sorensen N, Kuhl J. Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome. J Clin Oncol 1998;16:2478-85.
8. Maris JM, Matthay KK. Molecular biology of neuroblastoma. J Clin Oncol 1999;17:2264.
9. Fuller GN, Bigner SH. Amplified cellular oncogenes in neoplasms of the human central nervous system. Mutat Res 1992;276:299-306.
10. Garson JA, Pemberton LF, Sheppard PW, Varndell IM, Coakham HB, Kemshead JT. N-myc gene expression and oncoprotein characterisation in medulloblastoma. Br J Cancer 1989;59:889-94.
11. Nisen PD, Zimmerman KA, Cotter SV, Gilbert F, Alt FW. Enhanced expression of the N-myc gene in Wilms' tumors. Cancer Res 1986;46:6217-22.
12. Schwab M. Amplification of oncogenes in human cancer cells. Bioessays 1998;20:473-9.
13. Schneider SS, Hiemstra JL, Zehnbauer BA, et al. Isolation and structural analysis of a 1.2-megabase N-myc amplicon from a human neuroblastoma. Mol Cell Biol 1992;12:5563-70.
14. Akiyama K, Kanda N, Yamada M, Tadokoro K, Matsunaga T, Nishi Y. Megabase-scale analysis of the origin of N-myc amplicons in human neuroblastomas. Nucleic Acids Res 1994;22:187-93.
15. Squire JA, Thorner PS, Weitzman S, er al. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma. Oncogene 1995;10:1417-22.
16. Wimmer K, Zhu XX, Lamb BJ, et al. Co-amplification of a novel gene, NAG, with the N-myc gene in neuroblastoma. Oncogene 1999;18:233-8.
17. Smiraglia DJ, Frühwald MC, Costello JF, et al. A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from RLGS gels. Genomics 1999;58:254-262.
18. Hirotsune S, Hatada I, Komatsubara H, et al. New approach for detection of amplification in cancer DNA using restriction landmark genomic scanning. Cancer Res 1992;52: 3642-7.
19. Curtis LJ, Li Y, Gerbault-Seureau M, et al. Amplification of DNA sequences from chromosome 19q13.1 in human pancreatic cell lines. Genomics 1998;53:42-55.
20. Pietsch T, Scharmann T, Fonatsch C, et al. Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system. Cancer Res 1994;54:3278-87.
21. Plass C, Shibata H, Kalcheva I, et al. Identification of Grfl on mouse chromosome 9 as an imprinted gene by RLGS-M. Nat Genet 1996;14:106-9.
22. Yoshikawa H, de la Monte S, Nagai H, Wands JR, Matsubara K, Fujiyama A. Chromosomal assignment of human genomic NotI restriction fragments in a two-dimensional electrophoresis profile. Genomics 1996;31:28-35.
23. Plass C, Weichenhan D, Catanese J, et al. An arrayed human Not I-EcoRV boundary library as a tool for RLGS spot analysis. DNA Res 1997;4:253-5.
24. Miano JM, Krahe R, Garcia E, Elliott JM, Olson EN. Expression, genomic structure and high resolution mapping to 19p13.2 of the human smooth muscle cell calponin gene. Gene 1997;197:215-24.
25. Hudson TJ, Stein LD, Gerety SS, et al. An STS-based map of the human genome. Science 1995;270:1945-54.
26. Gyapay G, Schmitt K, Fizames G, et al. A radiation hybrid map of the human genome. Hum Mol Genet 1996;5:339-46.
27. Stewart EA, McKusick KB, Aggarwal A, et al. An STS-based radiation hybrid map of the human genome. Genome Res 1997;7:422-33.
28. Miano JM, Garcia E, Krahe R. High resolution radiation hybrid (RH) mapping of human smooth muscle-restricted genes. In: Baker AH, ed. Molecular biology of vascular diseases. Methods in Molecular Medicine Series. New York: Humana Press, 1999:25-35.
29. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992;258:818-21.
30. Kuroda H, White PS, Sulman EP, et al. Physical mapping of the DDX1 gene to 340 kb 5′ of MYCN. Oncogene 1996;13: 1561-5.
31. Miwa W, Yashima K, Sekine T, Sekiya T. Demethylation of a repetitive DNA sequence in human cancers. Electrophoresis 1995;16:227-32.
32. Thoraval D, Asakawa J, Wimmer K, et al. Demethylation of repetitive DNA sequences in neuroblastoma. Genes Chrom Cancer 1996;17:234-44.
33. Reardon DA, Michalkiewicz E, Boyett JM, et al. Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization. Cancer Res 1997;57: 4042-7.
34. Bigner SH, Friedman HS, Vogelstein B, Oakes WJ, Bigner DD. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts. Cancer Res 1990;50:2347-50.
35. Bruggers CS, Tai KF, Murdock T, et al. Expression of the c-Myc protein in childhood medulloblastoma. J Pediatr Hematol Oncol 1998;20:18-25.
36. Deloukas P, Schuler GD, Gyapay G, et al. A physical map of 30,000 human genes. Science 1998;282:744-6.
37. Rouah E, Wilson DR, Armstrong DL, Darlington GJ. N-myc amplification and neuronal differentiation in human primitive neuroectodermal tumors of the central nervous system. Cancer Res 1989;49:1797-801.
38. Wasson JC, Saylors RLD, Zeltzer P, et al. Oncogene amplification in pediatric brain tumors. Cancer Res 1990;50:2987-90.
39. Costello JF, Plass C, Arap W, et al. Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. Cancer Res 1997;57:1250-4.
40. Costello JF, Frühwald MC, Smiraglia DJ, et al. Aberrant CpG island methylation has non-random and tumor type specific patterns. Nat Genet 2000;25:132-8.
41. Plass C, Yu F, Yu L, et al. Restriction landmark genome scanning for aberrant methylation in primary refractory and relapsed acute myeloid leukemia; involvement of the WIT-1 gene. Oncogene 1999;18:3159-65.
42. George RE, Kenyon RM, McGuckin AG, Malcolm AJ, Pearson AD, Lunec J. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group. Oncogene 1996;12:1583-7.
43. Reiter JL, Brodeur GM. High-resolution mapping of a 130-kb core region of the MYCN amplicon in neuroblastomas. Genomics 1996;32:97-103.
44. Reiter JL, Brodeur GM. MYCN is the only highly expressed gene from the core amplified domain in human neuroblastomas. Genes Chrom Cancer 1998;23:134-40.